Femasys Past Earnings Performance
Past criteria checks 0/6
Femasys's earnings have been declining at an average annual rate of -20.1%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
-20.1%
Earnings growth rate
74.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 0.8% |
| Return on equity | -303.3% |
| Net Margin | -1,436.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry?
Oct 31
Shareholders May Be More Conservative With Femasys Inc.'s (NASDAQ:FEMY) CEO Compensation For Now
Jul 05Health Check: How Prudently Does Femasys (NASDAQ:FEMY) Use Debt?
Apr 03Here's Why We're Watching Femasys' (NASDAQ:FEMY) Cash Burn Situation
Sep 27Femasys commercially launches Femcerv for cervical cancer screening
Sep 29Femasys GAAP EPS of -$0.22 beats by $0.01, revenue of $0.3M misses by $0.01M
Aug 10We Think Femasys (NASDAQ:FEMY) Needs To Drive Business Growth Carefully
May 22Femasys: Revolutionizing Female Reproduction
Jul 16Revenue & Expenses Breakdown
How Femasys makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1 | -18 | 10 | 8 |
| 30 Jun 24 | 1 | -17 | 9 | 8 |
| 31 Mar 24 | 1 | -15 | 8 | 7 |
| 31 Dec 23 | 1 | -14 | 8 | 7 |
| 30 Sep 23 | 1 | -13 | 7 | 6 |
| 30 Jun 23 | 1 | -12 | 6 | 6 |
| 31 Mar 23 | 1 | -11 | 6 | 6 |
| 31 Dec 22 | 1 | -11 | 6 | 6 |
| 30 Sep 22 | 1 | -11 | 6 | 6 |
| 30 Jun 22 | 1 | -10 | 5 | 5 |
| 31 Mar 22 | 1 | -9 | 5 | 5 |
| 31 Dec 21 | 1 | -8 | 4 | 4 |
| 30 Sep 21 | 1 | -7 | 4 | 4 |
| 30 Jun 21 | 1 | -6 | 3 | 4 |
| 31 Mar 21 | 1 | -7 | 3 | 4 |
| 31 Dec 20 | 1 | -7 | 3 | 4 |
| 31 Dec 19 | 1 | -11 | 5 | 7 |
Quality Earnings: FEMY is currently unprofitable.
Growing Profit Margin: FEMY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FEMY is unprofitable, and losses have increased over the past 5 years at a rate of 20.1% per year.
Accelerating Growth: Unable to compare FEMY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FEMY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: FEMY has a negative Return on Equity (-303.25%), as it is currently unprofitable.